Stoke Therapeutics Ownership & Insider Activity

Stoke Therapeutics (STOK) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 0.8% of shares outstanding. Institutional investors hold 56.7%. Over the past 90 days, insiders made 4 sales worth $422K.

Shares Outstanding

62.282M

Shares Float

59.878M

Insider Shares Owned

547.315K

Insider % Owned

0.8%

Institutional Shares Held

36.593M

Institutional % Held

56.7%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$422K total

Net Activity

Net Selling

Net Value (90d)

-$422K

Stoke Therapeutics Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Oct 2, 2026	Jonathan Allan	GENERAL COUNSEL & CORP SEC	SELL	627.000	$26.33	$17K
Oct 1, 2026	Barry Ticho	CHIEF MEDICAL OFFICER	SELL	1.051K	$26.16	$27K
Sep 1, 2026	Barry Ticho	CHIEF MEDICAL OFFICER	SELL	5.545K	$30.67	$170K
Aug 14, 2026	Barry Ticho	CHIEF MEDICAL OFFICER	SELL-OPTIONS	5.233K	$32.03	$153K
Aug 14, 2026	MD Edward Kaye	—	SELL-OPTIONS	13.683K	$32.03	$403K
Aug 14, 2026	Jonathan Allan	GENERAL COUNSEL & CORP SEC	SELL-OPTIONS	3.139K	$32.03	$92K
Aug 3, 2026	Barry Ticho	CHIEF MEDICAL OFFICER	SELL	7.176K	$29.04	$208K
Jul 1, 2026	Barry Ticho	CHIEF MEDICAL OFFICER	SELL	7.228K	$32.66	$236K
Jun 16, 2026	Jonathan Allan	GENERAL COUNSEL & CORP SEC	SELL	1.457K	$29.95	$44K
Jun 1, 2026	Barry Ticho	CHIEF MEDICAL OFFICER	SELL	1.795K	$30.58	$55K
May 1, 2026	Barry Ticho	CHIEF MEDICAL OFFICER	SELL	2.243K	$32.79	$74K